Regulation of somatostatin receptor signaling
Regulation of somatostatin receptor signaling
批准号:
8495448
负责人:
AGNES SCHONBRUNN
金额:
$11.4万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-01 至 2015-06-30
关键词:
AddressAffectAffinityAgonistAntibodiesArrestinsBar CodesBindingBiochemical MarkersBiochemical ProcessBiologicalBiologyCarcinoid TumorCell LineCell membraneCell physiologyCellsCharacteristicsClinicalClinical TrialsComplementCoupledDevelopmentDrug Delivery SystemsEffectivenessEnvironmentEnzymesEventFamilyFoundationsFundingG Protein-Coupled Receptor GenesG-Protein-Coupled ReceptorsGTP-Binding ProteinsGastrointestinal HormonesGoalsHormonalHormonesHumanIndividualInterventionKnowledgeLeadLifeLigandsModelingMolecularMultienzyme ComplexesNatureNeuroendocrine CellNeuroendocrine TumorsNormal tissue morphologyOccupationsOctreotidePancreatic HormonesPatientsPatternPeptidesPharmaceutical PreparationsPhase III Clinical TrialsPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPituitary GlandPituitary HormonesPituitary NeoplasmsPlayProcessProtein DephosphorylationProtein IsoformsProteinsReceptor SignalingRecyclingRegulationResistanceResistance developmentRoleSOM-230Second Messenger SystemsSeriesSignal PathwaySignal TransductionSiteSomatostatinSomatostatin Analog TherapySomatostatin ReceptorSorting - Cell MovementTailTestingTherapeuticTimeTissuesTransmembrane DomainTumor TissueWorkanalogbasecancer diagnosiscell typedesensitizationeffective therapyimprovedinsightneoplastic cellnovelpreventprototypereceptorreceptor bindingreceptor functionreceptor internalizationresearch studyresponsesecond messengersomatostatin analogtherapeutic targettherapy resistanttraffickingtumortumor growth
中文摘要
描述(申请人提供):生长抑素受体信号的调节(Schonbrunn)生长抑素(SS)受体2A(Sstr2A)是正常组织和人类肿瘤中表达最广泛的SS受体亚型。在许多生物学作用中,它在调节垂体、胰腺和胃肠激素的分泌方面发挥着重要的生理作用。它也是SS类似物用于治疗垂体和胃肠胰脏神经内分泌肿瘤患者的治疗靶点,以抑制激素高分泌和减少肿瘤生长。不幸的是,很大一部分患者从一开始就对SS类似物治疗产生抗药性,其他患者在治疗过程中产生抗药性。造成这种情况的原因尚不清楚。为了加深对SS作用的了解,提高SS的治疗应用,我们的长期目标是阐明SS受体信号转导中涉及的分子事件,以及调节受体功能以产生靶细胞抵抗的机制。我们以前的研究表明,激素结合刺激了sstr2A在多个丝氨酸和苏氨酸上的快速和特异的磷酸化,我们已经确定了这一点。受体磷酸化改变了sstr2A信号转导和亚细胞转运,特定的磷酸化位点对受体功能有明显影响。出乎意料的是,受体磷酸化的模式因不同的配体而显著不同,包括那些目前正在进行临床试验的配体。这个建议的目的是确定sstr2AI的磷酸化是如何控制的,以及它是如何影响受体信号和运输的。这些研究的组织假设是,sstr2A的磷酸化和去磷酸化受到严格调控,以产生具有不同模式的磷酸化残基的受体--所谓的磷酸化“条形码”。我们认为这些差异磷酸化的受体是在不同的细胞间隔产生的,并决定了受体与特定的胞浆蛋白的相互作用,然后产生细胞对SS和SS类似物刺激的反应。这一假设将在四个具体目标中得到验证:(1)确定特定Ser/Thr残基的磷酸化如何影响sstr2A的运输和信号转导;(2)确定
调节受体的磷酸化状态的酶。我们将完成对sstr2A磷酸化的激酶的鉴定,并将以亚磷酸盐特异的方式表征催化sstr2A去磷酸化的酶复合体。我们还将确定特定的磷酸酶如何作用于受体的特定亚细胞室,(3)阐明在垂体和胃肠胰腺肿瘤细胞中产生细胞类型特异性差异的sstr2A磷酸化、运输和信号的机制,以及(4)阐明激动剂特异性sstr2A运输和脱敏的机制。这些研究将为我们提供对
调节sstr2A以及其他G蛋白偶联受体的生化和细胞过程,以及不同激动剂和细胞环境影响这些过程的方式。
英文摘要
DESCRIPTION (provided by applicant): Regulation of somatostatin receptor signaling (Schonbrunn) Somatostatin (SS) receptor 2A (sstr2A) is the most widely expressed SS receptor subtype in normal tissues and human tumors. It plays a critical physiological role in regulating pituitary, pancreatic and gastrointestinal hormone secretion, among many biological actions. It is also the therapeutic target for the SS analogs used to treat patients with pituitary and gastro-enteropancreatic neuroendocrine tumors in order to inhibit hormonal hyper-secretion and to reduce tumor growth. Unfortunately, a large fraction of patients are resistant to SS analog therapy from the start and others develop resistance during the course of treatment. The reasons for this are unknown. To increase our understanding of SS action and improve its therapeutic applications our long term goal is to elucidate the molecular events involved in SS receptor signaling and the mechanisms which regulate receptor function to produce target cell resistance. Our previous studies showed that hormone binding stimulates the rapid and specific phosphorylation of sstr2A at multiple Ser and Thr, which we have identified. Receptor phosphorylation alters both sstr2A signaling and subcellular trafficking, with specific phosphorylation sites exerting distinct effects on receptor function. Unexpectedly, the pattern of receptor phosphorylation varies dramatically with different ligands, including those currently in clinical trials. The objective of this proposal is to determine how the phosphorylation of sstr2A i controlled and how it affects receptor signaling and trafficking. The organizing hypothesis for these studies is that phosphorylation and dephosphorylation of sstr2A are stringently regulated in order to produce receptors with distinct patterns of phosphorylated residues - a so-called phosphorylation "bar code". We propose that these differentially phosphorylated receptors are generated in different cellular compartments and determine the interactions of the receptor with specific cytosolic proteins that then produce the cellular response to SS and SS analog stimulation. This hypothesis will be tested in four specific aims: (1) Determine how phosphorylation of specific Ser/Thr residues affects sstr2A trafficking and signaling, (2) Identify
the enzymes that regulate the phosphorylation state of the receptor. We will complete the identification of the kinases that phosphorylate sstr2A and will characterize the enzyme complexes that catalyze sstr2A dephosphorylation in a phosphosite- specific manner. We will also determine how specific phosphatases are directed to act on the receptor in particular subcellular compartments, (3) Elucidate the mechanisms that produce cell-type specific differences in sstr2A phosphorylation, trafficking, and signaling in pituitary and gastroenteropancreatic tumor cells, and (4) Elucidate the mechanisms responsible for agonist-specific sstr2A trafficking and desensitization. These studies will provide novel insights into the
biochemical and cellular processes which regulate sstr2A, as well as other G protein coupled receptors, and the manner in which different agonists and the cellular environment impact those processes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Regulation of somatostatin receptor signaling by receptor interacting proteins.
-
批准号:9269652
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2016
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:6380469
-
项目类别:
-
资助金额:$30.8万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
Function and Regulation of Somatostatin Receptors
-
批准号:7655248
-
项目类别:
-
资助金额:$33.11万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:2138775
-
项目类别:
-
资助金额:$23.27万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:6198385
-
项目类别:
-
资助金额:$28.91万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
Function and Regulation of Somatostatin Receptors
-
批准号:7254130
-
项目类别:
-
资助金额:$33.79万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:6769568
-
项目类别:
-
资助金额:$33.43万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:2443958
-
项目类别:
-
资助金额:$24.46万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:2734017
-
项目类别:
-
资助金额:$25.43万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
Function and Regulation of Somatostatin Receptors
-
批准号:7431681
-
项目类别:
-
资助金额:$33.11万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:6634890
-
项目类别:
-
资助金额:$32.47万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:2138776
-
项目类别:
-
资助金额:$23.53万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
Function and Regulation of Somatostatin Receptors
-
批准号:7143319
-
项目类别:
-
资助金额:$34.79万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
FUNCTION AND REGULATION OF SOMATOSTATIN RECEPTORS
-
批准号:6517055
-
项目类别:
-
资助金额:$31.63万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
Function and Regulation of Somatostatin Receptors
-
批准号:7878562
-
项目类别:
-
资助金额:$32.78万
-
财政年份:1995
-
负责人:AGNES SCHONBRUNN
-
依托单位:
MOLECULAR BIOLOGY OF SOMATOSTATIN RECEPTORS
-
批准号:3426208
-
项目类别:
-
资助金额:$2.97万
-
财政年份:1993
-
负责人:AGNES SCHONBRUNN
-
依托单位:
NEUROPEPTIDE AND TRANSMITTER ACTION IN SECRETORY CELLS
-
批准号:3230656
-
项目类别:
-
资助金额:$14.33万
-
财政年份:1988
-
负责人:AGNES SCHONBRUNN
-
依托单位:
SOMATOSTATIN RECEPTOR STRUCTURE AND FUNCTION
-
批准号:3230655
-
项目类别:
-
资助金额:$19.41万
-
财政年份:1988
-
负责人:AGNES SCHONBRUNN
-
依托单位:
NEUROPEPTIDE AND TRANSMITTER ACTION IN SECRETORY CELLS
-
批准号:3230654
-
项目类别:
-
资助金额:$16.84万
-
财政年份:1988
-
负责人:AGNES SCHONBRUNN
-
依托单位:
SOMATOSTATIN RECEPTOR STRUCTURE AND FUNCTION
-
批准号:2138774
-
项目类别:
-
资助金额:$20.36万
-
财政年份:1988
-
负责人:AGNES SCHONBRUNN
-
依托单位:
海外基金